GR3033745T3 - Combination of atovaquone with proguanil for the treatment of protozoal infections. - Google Patents

Combination of atovaquone with proguanil for the treatment of protozoal infections.

Info

Publication number
GR3033745T3
GR3033745T3 GR20000401440T GR20000401440T GR3033745T3 GR 3033745 T3 GR3033745 T3 GR 3033745T3 GR 20000401440 T GR20000401440 T GR 20000401440T GR 20000401440 T GR20000401440 T GR 20000401440T GR 3033745 T3 GR3033745 T3 GR 3033745T3
Authority
GR
Greece
Prior art keywords
proguanil
atovaquone
treatment
combination
protozoal infections
Prior art date
Application number
GR20000401440T
Other languages
English (en)
Inventor
Winston Edward Gutteridge
David Brian Ashton Hutchinson
Victoria Susan Latter
Mary Pudney
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10725687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3033745(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of GR3033745T3 publication Critical patent/GR3033745T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR20000401440T 1992-11-26 2000-06-22 Combination of atovaquone with proguanil for the treatment of protozoal infections. GR3033745T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224739A GB9224739D0 (en) 1992-11-26 1992-11-26 Medicaments
PCT/GB1993/002425 WO1994012164A1 (en) 1992-11-26 1993-11-25 Combination of atovaquone with proguanil for the treatment of protozoal infections

Publications (1)

Publication Number Publication Date
GR3033745T3 true GR3033745T3 (en) 2000-10-31

Family

ID=10725687

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401440T GR3033745T3 (en) 1992-11-26 2000-06-22 Combination of atovaquone with proguanil for the treatment of protozoal infections.

Country Status (38)

Country Link
US (3) US5998449A (el)
EP (1) EP0670719B1 (el)
JP (1) JP3768231B2 (el)
KR (1) KR100294802B1 (el)
CN (1) CN1087935C (el)
AP (1) AP517A (el)
AT (1) ATE191340T1 (el)
AU (1) AU685408B2 (el)
BG (1) BG62595B1 (el)
CA (1) CA2150234E (el)
CY (1) CY2193B1 (el)
CZ (2) CZ289171B6 (el)
DE (1) DE69328307T2 (el)
DK (1) DK0670719T3 (el)
ES (1) ES2145114T3 (el)
GB (1) GB9224739D0 (el)
GR (1) GR3033745T3 (el)
HK (1) HK1004468A1 (el)
HU (1) HU225918B1 (el)
IL (1) IL107755A (el)
MX (1) MX9307402A (el)
MY (1) MY114241A (el)
NO (1) NO313225B1 (el)
NZ (1) NZ257901A (el)
OA (1) OA10352A (el)
PE (1) PE55694A1 (el)
PL (1) PL174323B1 (el)
PT (1) PT670719E (el)
RO (1) RO119280B1 (el)
RU (1) RU2108092C1 (el)
SA (1) SA93140434B1 (el)
SG (1) SG45387A1 (el)
SI (1) SI9300614A (el)
SK (1) SK281559B6 (el)
TW (1) TW253835B (el)
UA (1) UA45948C2 (el)
WO (1) WO1994012164A1 (el)
ZA (1) ZA938832B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
GB9822681D0 (en) * 1998-10-16 1998-12-09 Vitabiotics Ltd Method of treatment
ES2199817T3 (es) * 1999-04-09 2004-03-01 Glaxo Group Limited Preparacion combinada para tratar la malaria.
US7104076B2 (en) * 2004-06-24 2006-09-12 Carrier Corporation Lubricant return schemes for use in refrigerant cycle
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
WO2011021230A2 (en) * 2009-08-20 2011-02-24 Ipca Laboratories Limited Novel complex for treatment and/or prophylaxis of parasitic infections
US20180055835A1 (en) 2016-08-25 2018-03-01 Immune Therapeutics Inc. Method for Treating And Preventing Protozoal Infections

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
NL6411993A (el) * 1963-10-18 1965-04-20
US3347830A (en) * 1964-07-30 1967-10-17 Grace W R & Co Process of polymerizing formaldehyde
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
NL6817526A (el) * 1968-01-24 1969-07-28
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
DE2601458A1 (de) * 1975-01-20 1976-07-22 Ciba Geigy Ag Loesliche, von phenylindandiaminen abgeleitete polyamide
JPS5492945A (en) * 1977-11-22 1979-07-23 Wellcome Found Naphthoquinone derivative
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485117A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
JPS59196467A (ja) * 1983-04-23 1984-11-07 Nissan Motor Co Ltd 車輪速及びまたは車輪加減速度検出方法
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
ATE178311T1 (de) * 1988-08-16 1999-04-15 Wellcome Found Neue naphthochinone und ihre anwendung als arzneimittel
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
US5014737A (en) * 1989-11-13 1991-05-14 Allan Berman Quartz integrated trough/sump recirculating filtered high-purity chemical bath
GB9121316D0 (en) * 1991-10-09 1991-11-20 Wellcome Found Heterocyclic compounds
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
ATE143601T1 (de) * 1993-05-05 1996-10-15 Palo Alto Medical Found Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
US5733932A (en) * 1995-01-06 1998-03-31 The Picower Institute For Medical Research Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
ZA983331B (en) * 1997-05-01 1998-10-27 Allegheny University Of The He Method for treating protozoal infections
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
ES2199817T3 (es) * 1999-04-09 2004-03-01 Glaxo Group Limited Preparacion combinada para tratar la malaria.

Also Published As

Publication number Publication date
US5998449A (en) 1999-12-07
CN1087935C (zh) 2002-07-24
AP9300592A0 (en) 1994-01-31
ATE191340T1 (de) 2000-04-15
SK281559B6 (sk) 2001-05-10
CA2150234E (en) 2005-03-22
GB9224739D0 (en) 1993-01-13
HU9501537D0 (en) 1995-07-28
BG62595B1 (bg) 2000-03-31
SA93140434B1 (ar) 2004-09-01
PL174323B1 (pl) 1998-07-31
CZ289692B6 (cs) 2002-03-13
HU225918B1 (en) 2007-12-28
DK0670719T3 (da) 2000-07-31
CZ289171B6 (cs) 2001-11-14
TW253835B (el) 1995-08-11
EP0670719A1 (en) 1995-09-13
HUT71346A (en) 1995-11-28
NO951995D0 (no) 1995-05-19
AU685408B2 (en) 1998-01-22
DE69328307T2 (de) 2000-10-26
CN1091632A (zh) 1994-09-07
KR100294802B1 (ko) 2001-09-17
AP517A (en) 1996-08-23
RU2108092C1 (ru) 1998-04-10
CA2150234A1 (en) 1994-06-09
PE55694A1 (es) 1995-01-25
PT670719E (pt) 2000-09-29
US6291488B1 (en) 2001-09-18
NO313225B1 (no) 2002-09-02
PL309222A1 (en) 1995-10-02
NZ257901A (en) 1997-01-29
WO1994012164A1 (en) 1994-06-09
BG99656A (bg) 1996-04-30
SK57095A3 (en) 1996-05-08
IL107755A (en) 2000-10-31
MY114241A (en) 2002-09-30
DE69328307D1 (de) 2000-05-11
ZA938832B (en) 1995-05-25
IL107755A0 (en) 1994-02-27
NO951995L (no) 1995-07-03
SI9300614A (en) 1994-06-30
US6166046A (en) 2000-12-26
UA45948C2 (uk) 2002-05-15
SG45387A1 (en) 1998-01-16
RO119280B1 (ro) 2004-07-30
HK1004468A1 (en) 1998-11-27
AU5532294A (en) 1994-06-22
JPH08503938A (ja) 1996-04-30
CY2193B1 (en) 2002-11-08
ES2145114T3 (es) 2000-07-01
MX9307402A (es) 1994-07-29
CZ119295A3 (en) 1995-11-15
EP0670719B1 (en) 2000-04-05
OA10352A (en) 2001-10-22
CA2150234C (en) 2001-01-16
JP3768231B2 (ja) 2006-04-19

Similar Documents

Publication Publication Date Title
EP0678723A4 (en) NIZOV CROSSBOW.
EP0604033A3 (en) Sealing arrangement.
EP0655256A3 (en) Inhaler.
EP0630671A3 (en) Wastewater treatment system.
EP0597463A3 (en) Thermotherapiesonde.
EP0642805A3 (en) Catheter with deactivable lateral opening.
EP0588602A3 (en) Lamps.
EP0580285A3 (en) Auto-reclosers.
EP0628760A3 (en) Pipe connection.
EP0581462A3 (en) Humidifier.
EP0608546A3 (en) Glia activating factor (gaf), antibodies against it and their uses.
EP0604025A3 (en) Image forming method.
EP0602808A3 (en) Cache systems.
EP0596196A3 (de) Dichtungsanordnung.
GR3033745T3 (en) Combination of atovaquone with proguanil for the treatment of protozoal infections.
EP0637053A3 (de) Elektronenröhre.
EP0667099A4 (en) OVEN COOKING PROCESS.
GR3021203T3 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane.
EP0660449A3 (en) Electrical leadthrough and its manufacture, as well as device that uses the leadthrough.
EP0600282A3 (de) Alkalicyanid-Granulate und Verfahren zu ihrer Herstellung.
EP0589606A3 (en) Electron cannon devices.
ZA9314B (en) Chemical process.
EP0599191A3 (en) Engine speed control circuit.
EP0592354A3 (de) Vakuum-Zentrifuge.
AU6130194A (en) 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections